SC
OGI

Steven Cohen’s Organigram Holdings OGI Stock Holding History

Steven Cohen’s Portfolio OGI Stock Details OGI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,764
Closed -$14.5K – 4430
2026
Q1 		$14.5K Sell
10,764
-114,448
-91% -$170K ﹤0.01% 3691
2025
Q4 		$210K Buy
+125,212
New +$215K ﹤0.01% 3622

Other funds holding OGI

TI
Tidal Investments Milwaukee, Wisconsin $57.8B AUM 72.54% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
FAM
Formidable Asset Management Cincinnati, Ohio $629M AUM 15.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return

Steven Cohen's OGI Position: Q2 2026 in Review

Steven Cohen sold out of Organigram Holdings (OGI) in Q2 2026, closing a stake of 10,764 shares — an estimated $14.5K sold.

Steven Cohen first reported a position in OGI in Q4 2025 and held it in 2 quarters. The position peaked at $210K in Q4 2025. 70 funds tracked by Wall St. Rank hold OGI as of Q2 2026.

  • Steven Cohen reported no remaining Organigram Holdings position as of Q2 2026 after selling out during the quarter.
  • Steven Cohen sold 10,764 Organigram Holdings shares in Q2 2026, an estimated $14.5K.
  • Steven Cohen first reported a position in Organigram Holdings in Q4 2025 and held it in 2 quarters.
  • Steven Cohen's Organigram Holdings position peaked at $210K in Q4 2025.
  • 70 funds tracked by Wall St. Rank held Organigram Holdings as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.